This functional dichotomy is further amplified by their ability to differentially regulate critical signaling hubs—such as simultaneously modulating NF-κB activation through TRAF3 deubiquitination while suppressing Wnt/β-catenin signaling via APC complex stabilization—effectively rewiring tumor cell fate decisions. The gene discussed is NFKB1; the disease is neoplasm.